NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation.
ثبت نشده
چکیده
منابع مشابه
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
Cardiovascular Disease in Dialysis Patients Tables ............................................................................................................................... S1 Figures ............................................................................................................................. S2 Acronyms and Abbreviations ......................................................
متن کاملAchievement of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative: recommended serum calcium, phosphate and parathyroid hormone values with parathyroidectomy in patients with secondary hyperparathyroidism
PURPOSE The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) 2003 has established guidelines for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease - minerals and bone disorder (CKD-MBD). This study evaluated parathyroidectomy in SHPT patients for the achievement of the NKF-K/DOQI-recommended values of serum calcium, p...
متن کاملVenous access for patients with chronic kidney disease.
ESTABLISHING and maintaining reliable intravenous access for patients with chronic renal failure or end-stage renal disease presents special considerations unique to this patient population. These patients often present with complicated medical conditions requiring intravenous medical therapies; at the same time, there is a critical need to preserve the peripheral and central veins for future h...
متن کاملClinical and Practical Perspectives on the Use of Intravenous vs. Subcutaneous Epoetin Alfa in Hemodialysis Patients {August 2001}
Background. The route of Epoetin alfa (EPO) administration has become a controversial issue in recent years. Despite the National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) guidelines recommending subcutaneous (SC) EPO for all dialysis patients, only 12% of hemodialysis patients in the U.S. receive EPO by the SC route. Methods. A telephone survey was undertaken to gather ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- American journal of kidney diseases : the official journal of the National Kidney Foundation
دوره 30 3 Suppl 2 شماره
صفحات -
تاریخ انتشار 1997